SINGAPORE – A new programme has been launched in Singapore to formally study the applications of ribonucleic acid (RNA) in vaccine development, as well as in disease therapy and prevention, to deepen Singapore’s competitive edge in the emerging space. The seven-year $130 million programme – dubbed the National Initiative for RNA Biology and Its Applications (Nirba) – is backed by the National Research Foundation (NRF). Announcing its launch on March 24 at the National University of Singapore (NUS), Deputy Prime Minister Heng Swee Keat said: “RNA biology and its applications are an important domain in foundational research.”   https://www.straitstimes.com/singapore/health/spore-launches-130m-rna-research-programme-to-tackle-a-wider-range-of-ailments   (ICE SINGAPORE)

Fonte notizia: The Straits Times, 24 March 2025